内脏脂肪组织及其评估指标与糖尿病肾病的研究进展
Visceral Adipose Tissue and Its Evaluation Index and the Research Progress of Diabetic Nephropathy
DOI: 10.12677/ACM.2023.1371622, PDF,  被引量   
作者: 张晓英, 韩彦渊：青海大学附属医院内分泌科，青海 西宁
关键词: 内脏脂肪组织；2型糖尿病；糖尿病肾病；Visceral Adipose Tissue； Type 2 Diabetes； Diabetic Kidney Disease
摘要: 近年来，糖尿病肾病(diabetic kidney disease, DKD)的发病率日趋升高，糖尿病肾病是糖尿病患者微血管病变的主要死亡原因，是导致终末期肾病(end stage renal disease, ESRD)的主要病因之一。内脏脂肪组织与腹性肥胖及胰岛素抵抗相关，内脏脂肪越多，糖尿病肾病的发生率越高。本综述详细介绍用来评估内脏脂肪组织的各个指标以及进一步探讨其与糖尿病肾病的关系。
Abstract: In recent years, the incidence of diabetic nephropathy (DKD) is increasing day by day. Diabetic nephropathy is the main cause of death of diabetic microangiopathy and one of the main causes of end stage renal disease, ESRD). Visceral adipose tissue is related to abdominal obesity and insulin resistance. The more visceral fat, the higher the incidence of diabetic nephropathy. This review in-troduces in detail the indexes used to evaluate visceral adipose tissue and further discusses its re-lationship with diabetic nephropathy.
文章引用：张晓英, 韩彦渊. 内脏脂肪组织及其评估指标与糖尿病肾病的研究进展[J]. 临床医学进展, 2023, 13(7): 11594-11600. https://doi.org/10.12677/ACM.2023.1371622

参考文献

[1] Cherney, D.I., Odutayo, A. and Verma, S. (2019) A Big Win for Diabetic Kidney Disease: Credence. Cell Metabolism, 29, 1024-1027. [Google Scholar] [CrossRef] [PubMed]
[2] Tönnies, T., Rathmann, W., Hoyer, A., Brinks, R. and Kuss, O. (2021) Quantifying the Underestimation of Projected Global Diabetes Prevalence by the International Dia-betes Federation (IDF) Diabetes Atlas. BMJ Open Diabetes Research & Care, 9, e002122. [Google Scholar] [CrossRef] [PubMed]
[3] Hou, J.H., Zhu, H.X., Zhou, M.L., et al. (2018) Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China. Kidney Dis-ease (Basel), 4, 10-19. [Google Scholar] [CrossRef] [PubMed]
[4] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304. [Google Scholar] [CrossRef] 
[5] Wang, Z. and Hoy, W.E. (2013) Diabetes and Life-time Risk of ESRD in High-Risk Remote-Dwelling Australian Aboriginal People: A 20-Year Cohort Study. American Journal of Kidney Diseases, 62, 845-846. [Google Scholar] [CrossRef] [PubMed]
[6] Lakkis, J.I. and Weir, M.R. (2018) Obesity and Kidney Disease. Progress in Cardiovascular Diseases, 61, 157-167. [Google Scholar] [CrossRef] [PubMed]
[7] Zhu, Q. and Scherer, P.E. (2018) Immunologic and Endocrine Functions of Adipose Tissue: Implications for Kidney Disease. Nature Reviews Nephrology, 14, 105-120. [Google Scholar] [CrossRef] [PubMed]
[8] Al Obaidi, R.M.S. (2021) The Physiological Effects of Visfatin on Immune Response and Inflammatory Impacts on Nephropathy. Archives of Razi Institute, 76, 639-647.
[9] Mashitani, T., Hayashino, Y., Okamura, S., Tsujii, S. and Ishii, H. (2014) Correlations between Serum Bilirubin Levels and Diabetic Nephropathy Progression among Japanese Type 2 Diabetic Patients: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 5]). Diabetes Care, 37, 252-258. [Google Scholar] [CrossRef] [PubMed]
[10] 曾慧妍, 曹瑛, 赵玲, 等. 肥胖相关指标与2型糖尿病肾病患病率的相关性分析[J]. 世界中西医结合杂志, 2014(6): 617-619, 623.
[11] 任伟, 郭剑津, 郗光霞, 李元宾, 高林琳, 李兴, 柳洁. 利拉鲁肽治疗对肥胖2型糖尿病患者早期肾损伤的治疗作用[J]. 中国药物与临床, 2015, 15(9): 1284-1286.
[12] Qiao, Q. and Nyamdorj, R. (2010) Is the Association of Type II Diabetes with Waist Circumference or Waist-to-Hip Ratio Stronger than That with Body Mass Index? European Journal of Clinical Nutrition, 64, 30-34. [Google Scholar] [CrossRef] [PubMed]
[13] Czernichow, S., Kengne, A.P., Stamatakis, E., Hamer, M. and Batty, G.D. (2011) Body Mass Index, Waist Circumference and Waist-Hip Ratio: Which Is the Better Discriminator of Cardiovascu-lar Disease Mortality Risk? Evidence from an Individual-Participant Meta-Analysis of 82864 Participants from Nine Co-hort Studies. Obesity Reviews, 12, 680-687. [Google Scholar] [CrossRef] 
[14] 任倩. 中国成人肥胖评价指标预测高血压发病适宜切点值的前瞻性研究[D]: [博士学位论文]. 北京: 中国疾病预防控制中心营养与健康所, 2016.
[15] Hsieh, S.D., Yoshinaga, H. and Muto, T. (2003) Waist-to-Height Ratio, a Simple and Prac-tical Index for Assessing Central Fat Distribution and Metabolic Risk in Japanese Men and Women. International Jour-nal of Obesity and Related Metabolic Disorders, 27, 610-616. [Google Scholar] [CrossRef] [PubMed]
[16] 方凤贞, 张璟. 不同肥胖指标对2型糖尿病肾脏疾病的预测及适宜切点值[J]. 中医临床研究, 2021, 13(31): 37-41.
[17] Amato, M.C., Giordano, C., Galia, M., et al. (2010) Visceral Adiposity Index: A Reliable Indicator of Vis-ceral Fat Function Associated with Cardiometabolic Risk. Diabetes Care, 33, 920-922. [Google Scholar] [CrossRef] [PubMed]
[18] Graffy, P.M. and Pickhardt, P.J. (2016) Quantification of Hepatic and Vis-ceral Fat by CT and MR Imaging: Relevance to the Obesity Epidemic, Metabolic Syndrome and NAFLD. The British Journal of Radiology, 89, Article ID: 20151024. [Google Scholar] [CrossRef] [PubMed]
[19] Amato, M.C. and Giordano, C. (2014) Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction. International Journal of Endocrinology, 2014, Article ID: 730827. [Google Scholar] [CrossRef] [PubMed]
[20] Kahn, H.S. (2005) The “Lipid Accumulation Product” Performs Better than the Body Mass Index for Recognizing Cardiovascular Risk: A Popula-tion-Based Comparison. BMC Cardiovascular Disorders, 5, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
[21] Deurenberg, P., Deurenberg-Yap, M. and Guricci, S. (2002) Asians Are Different from Caucasians and from Each Other in Their Body Mass Index/Body Fat Percent Relationship. Obesity Reviews, 3, 141-146. [Google Scholar] [CrossRef] 
[22] Yaghootkar, H., Whitcher, B., Bell, J.D. and Thomas, E.L. (2020) Ethnic Differences in Adiposity and Diabetes Risk—Insights from Genetic Studies. Journal of Internal Medicine, 288, 271-283. [Google Scholar] [CrossRef] [PubMed]
[23] Xia, M.F., Chen, Y., Lin, H.D., et al. (2016) A Indicator of Visceral Adipose Dysfunction to Evaluate Metabolic Health in Adult Chinese. Scientific Reports, 6, Article No. 38214. [Google Scholar] [CrossRef] [PubMed]
[24] Wan, H., Wang, Y., Xiang, Q., et al. (2020) Associations between Ab-dominal Obesity Indices and Diabetic Complications: Chinese Visceral Adiposity Index and Neck Circumference. Car-diovascular Diabetology, 19, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
[25] Bello-Chavolla, O.Y., Almeda-Valdes, P., Gomez-Velasco, D., et al. (2018) METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes. European Journal of Endocrinology, 178, 533-544. [Google Scholar] [CrossRef] 
[26] Liu, X.Z., Fan, J. and Pan, S.J. (2019) METS-IR, a Novel Simple Insulin Resistance Indexes, Is Associated with Hyperten-sion in Normal-Weight Chinese Adults. Journal of Clinical Hypertension (Greenwich, Conn.), 21, 1075-1081. [Google Scholar] [CrossRef] [PubMed]
[27] 林海玲, 邱山虎, 胡浩, 刘钰, 陈娟, 李婷婷, 刘佳宁, 袁扬, 孙子林. 中国人群胰岛素抵抗代谢指数与慢性肾脏病及蛋白尿的相关性分析[J]. 中华内科杂志, 2023, 62(3): 281-289.
[28] Lanaspa, M.A., Ishimoto, T., Cicerchi, C., et al. (2014) Endogenous Fructose Production and Fructoki-nase Activation Mediate Renal Injury in Diabetic Nephropathy. Journal of the American Society of Nephrology, 25, 2526-2538. [Google Scholar] [CrossRef] 
[29] Albu, J.B., Kovera, A.J. and Johnson, J.A. (2000) Fat Distribution and Health in Obesity. Annals of the New York Academy of Sciences, 904, 491-501. [Google Scholar] [CrossRef] [PubMed]
[30] 陆玉敏, 黄仲奎, 龙莉玲. 人体脂肪含量及分布DEXA测量的可行性研究[J]. 实用放射学杂志, 2007, 23(1): 70-74. [Google Scholar] [CrossRef] 
[31] Asano, T., Kubota, N., Koizumi, N., et al. (2017) Nov-el and Simple Ultrasonographic Methods for Estimating the Abdominal Visceral Fat Area. International Journal of En-docrinology, 2017, Article ID: 8796069. [Google Scholar] [CrossRef] [PubMed]
[32] Gomi, T., Kawawa, Y., Nagamoto, M., Terada, H. and Kohda, E. (2005) Measurement of Visceral Fat/Subcutaneous Fat Ratio by 0.3 Tesla MRI. Radiation Medicine, 23, 584-587.
[33] 孙立平. 内脏脂肪的测量和胰岛素抵抗[J]. 胡世红, 审校. 医学综述, 2008, 14(13): 1986-1988.
[34] Examination Commit-tee of Criteria for “Obesity Disease” in Japan, Japan Society for the Study of Obesity (2002) New Criteria for “Obesity Disease” in Japan. Circulation Journal, 66, 987-992. [Google Scholar] [CrossRef] [PubMed]
[35] Jang, Y., Kim, O.Y., Ryu, H.J., et al. (2003) Visceral Fat Accumulation Determines Postprandial Lipemic Response, Lipid Peroxidation, DNA Damage, and Endothelial Dysfunction in Nonobese Korean Men. Journal of Lipid Research, 44, 2356-2364. [Google Scholar] [CrossRef] 
[36] 王惠玲, 谭擎缨, 王秀景, 王静, 阮勇, 阮芸, 姚佳琦. BMI正常男性2型糖尿病患者腹腔内脏脂肪面积与胰岛素抵抗的关系[J]. 中华全科医师杂志, 2015(8): 599-602.
[37] Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F.C. and Sharma, A.M. (2005) Weight Loss and the Renin-Angiotensin-Aldosterone System. Hypertension, 45, 356-362. [Google Scholar] [CrossRef] 
[38] Wisse, B.E. (2004) The Inflammatory Syndrome: The Role of Adipose Tissue Cytokines in Metabolic Disorders Linked to Obesity. Journal of the American Society of Neph-rology, 15, 2792-2800. [Google Scholar] [CrossRef] 
[39] Knight, S.F. and Imig, J.D. (2007) Obesity, Insulin Resistance, and Renal Function. Microcirculation, 14, 349-362. [Google Scholar] [CrossRef] [PubMed]
[40] Ma, R.C. and Chan, J.C. (2013) Type 2 Diabetes in East Asians: Similarities and Differences with Populations in Europe and the United States. Annals of the New York Academy of Sci-ences, 1281, 64-91. [Google Scholar] [CrossRef] [PubMed]
[41] Tanaka, S., Horimai, C. and Katsukawa, F. (2003) Ethnic Differences in Abdominal Visceral Fat Accumulation between Japanese, African-Americans, and Caucasians: A Meta-Analysis. Acta Diabetologica, 40, S302-S304. [Google Scholar] [CrossRef] [PubMed]

为你推荐